Sean Cole
π€ SpeakerAppearances Over Time
Podcast Appearances
I mean, in every case, they want to come up with something totally new if they can manage it.
A singularly unique name is the goal.
Trademarkability, for one thing, and just plain marketability.
They want the product to stand out.
But the main factor driving this ceaseless crusade for nominal innovation, Roman, is the FDA.
So two big things to focus on here.
Number one, what a drug seems to be promising.
The FDA doesn't want a name to sound like, oh, this is some miracle drug.
That is benign prostatic hyperplasia.
That same enlarged prostate condition that was the very first inspiration for the name Viagra.
I know how to determine maximum flow.